A detailed history of Everett Harris & CO transactions in Zoetis Inc. stock. As of the latest transaction made, Everett Harris & CO holds 4,930 shares of ZTS stock, worth $871,328. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,930
Previous 4,930 -0.0%
Holding current value
$871,328
Previous $854,000 12.76%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$145.54 - $178.83 $18,483 - $22,711
127 Added 2.64%
4,930 $854,000
Q4 2023

Jan 18, 2024

SELL
$151.44 - $200.09 $46,340 - $61,227
-306 Reduced 5.99%
4,803 $947,000
Q3 2023

Oct 23, 2023

SELL
$167.14 - $192.77 $1,337 - $1,542
-8 Reduced 0.16%
5,109 $888,000
Q2 2023

Jul 26, 2023

BUY
$160.94 - $186.23 $1,287 - $1,489
8 Added 0.16%
5,117 $881,000
Q4 2022

Jan 20, 2023

BUY
$131.14 - $157.47 $2,622 - $3,149
20 Added 0.39%
5,109 $0
Q2 2022

Jul 22, 2022

BUY
$155.97 - $200.09 $40,708 - $52,223
261 Added 5.41%
5,089 $875,000
Q1 2022

Apr 22, 2022

BUY
$181.39 - $234.03 $26,120 - $33,700
144 Added 3.07%
4,828 $911,000
Q4 2021

Feb 02, 2022

SELL
$193.69 - $247.03 $48,422 - $61,757
-250 Reduced 5.07%
4,684 $1.14 Million
Q1 2021

May 13, 2021

SELL
$144.0 - $169.39 $5,472 - $6,436
-38 Reduced 0.76%
4,934 $777,000
Q4 2020

Feb 04, 2021

BUY
$157.07 - $174.35 $5,968 - $6,625
38 Added 0.77%
4,972 $823,000
Q2 2019

Aug 13, 2019

BUY
$97.98 - $114.28 $19,889 - $23,198
203 Added 4.29%
4,934 $560,000
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $5,260 - $5,873
63 Added 1.35%
4,731 $433,000
Q2 2018

Jul 27, 2018

SELL
$79.9 - $89.2 $5,912 - $6,600
-74 Reduced 1.56%
4,668 $398,000
Q1 2018

Apr 20, 2018

BUY
$71.51 - $84.69 $9,725 - $11,517
136 Added 2.95%
4,742 $396,000
Q3 2017

Oct 11, 2017

BUY
$59.73 - $65.4 $275,116 - $301,232
4,606
4,606 $294,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.